Investor Presentaiton
Balance Sheet
RMB'million
Bank balances and cash
Other financial assets-current
Trade receivables
Deposits, prepayments and other receivables
Inventories
Total Current Assets
As at 30 June
2021
As at 31 December
2020
11,164.0
7,763.8
357.3
1,002.5
475.4
164.4
164.5
1,101.6
705.7
13,432.5
9,466.7
Property, plant and equipment
2,011.5
1,584.1
Right-of-Use assets
316.1
327.1
Intangible assets
96.9
32.6
Deposits for acquisition of property, plant and equipment 395.9
272.3
Other receivables and tax recoverables
158.2
139.3
Other financial assets
45.4
12.9
Total Non-current Assets
3,024.0
2,368.3
Total Assets
16,456.5
11,835.0
Trade payables
(277.3)
(120.6)
Other payables and accrued expenses
(1,369.4)
(973.7)
Contract liabilities
(210.2)
(120.4)
Borrowings
(370.0)
(255.0)
Lease liabilities
(14.9)
(16.2)
Total Current Liabilities
(2,241.8)
(1,485.9)
Contract liabilities
(779.7)
(588.1)
Borrowings-non
Government grants
Lease liabilities
Total Non-current Liabilities
Total Liabilities
Total Equity
Innovent
(58.5)
(45.8)
(1,468.1)
(925.2)
(3.1)
(10.2)
(2,309.4)
(1,569.3)
(4,551.2)
(3,055.2)
11,905.3
8,779.8
Note: Numbers may not add due to rounding
Confidential
Copyright©2021 Innovent Biologics
Cash balance
As at 30 June 2021, our total cash
increased to RMB11,164 million
(equivalent to US$1.7 billion)
43
33View entire presentation